
|Videos|July 24, 2023
Safety Profile of S1P Receptor Modulators for Multiple Sclerosis
Author(s)Krzysztof Selmaj, MD, PhD
Krzysztof Selmaj, MD, PhD, discusses the side effects of sphinogine-1-phospate (S1P) receptor modulators, highlighting particular adverse events clinicians should be aware of when treating multiple sclerosis (MS).
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NeuroVoices: Benjamin Tolchin, MD, FAAN, on First-Ever AAN Guidelines for Functional Seizures
2
Women Physicians Day 2026: Sex-Specific Clinical Considerations in Women With Epilepsy
3
Late-Breaking CHOICE 2 Data Indicate Alteplase Displayed Improved Stroke Recovery
4
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
5

























